Ford, J, Cummins, E, Sharma, P, Elders, A, Stewart, F, Johnston, R, Royle, P, Jones, R, Mulatero, C, Todd, R and Mowatt, G (2013) Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours. Health Technology Assessment, 17 (29). pp. 1-386. ISSN 1366-5278
Full text not available from this repository. (Request a copy)Abstract
Denosumab offers an alternative, or additional, treatment for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumours.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | antibodies, monoclonal, humanized,bone density conservation agents,bone neoplasms,breast neoplasms,cost-benefit analysis,female,humans,lung neoplasms,male,models, economic,prostatic neoplasms,quality-adjusted life years,randomized controlled trials as topic |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School Faculty of Science > School of Chemistry |
UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care |
Depositing User: | Pure Connector |
Date Deposited: | 12 Nov 2014 16:50 |
Last Modified: | 21 Oct 2022 00:15 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/50668 |
DOI: | 10.3310/hta17290 |
Actions (login required)
![]() |
View Item |